http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012500281-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2009-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012500281-A |
| titleOfInvention | Ethenyl substituted pyridine and pyrimidine derivatives and their use in the treatment of viral infections |
| abstract | The present invention relates to compounds of formula (A) (chemical formula should be inserted here as in the written summary) (A), and tautomers, isomers and esters of the compounds, and Pharmaceutically acceptable salts, solvates and prodrugs of the compounds are provided, wherein R, R 1 , X, Y, Z, R 2 , R 3 , R 4 , R 5 , R 6 , R Each of 7 , R 8 , R 9 , R 18 , R 19 , R 22 , R 23 and n is independently selected and is as defined herein. Compositions comprising such compounds are also provided. The compounds of the present invention are effective as inhibitors of HCV and are effective alone or in combination with other therapeutic agents in the treatment or prevention of diseases or disorders such as viral infections and virus-related disorders. |
| priorityDate | 2008-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 589.